MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis (Q33643505)

28 July 2017

0 references

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis (English)

1 reference

28 July 2017

1 reference

1 reference

Qiliu Peng

1

1 reference

28 July 2017

Cuiju Mo

2

1 reference

28 July 2017

Aiping Qin

3

1 reference

28 July 2017

Xianjun Lao

4

1 reference

28 July 2017

Zhiping Chen

5

1 reference

28 July 2017

Jingzhe Sui

6

1 reference

28 July 2017

Junrong Wu

7

1 reference

28 July 2017

Limin Zhai

8

1 reference

28 July 2017

Shi Yang

9

1 reference

28 July 2017

Xue Qin

10

1 reference

28 July 2017

Shan Li

11

1 reference

28 July 2017

language of work or name

1 reference

3 November 2013

1 reference

Journal of Experimental & Clinical Cancer Research

28 July 2017

1 reference

28 July 2017

32

1 reference

28 July 2017

85

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-9966-32-85

28 July 2017

0 references

cites work

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Genetic polymorphisms and endometrial cancer risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

MDM2 SNP309 is associated with endometrial cancer risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Obesity and gynaecological cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Uncertainty in heterogeneity estimates in meta-analyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Single nucleotide polymorphism: a new risk factor for endometrial cancer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Mdm2 in growth signaling and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Detection of genotyping errors by Hardy-Weinberg equilibrium testing.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Statistical aspects of the analysis of data from retrospective studies of disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Measuring inconsistency in meta-analyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Quantifying heterogeneity in a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Bias in meta-analysis detected by a simple, graphical test

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Meta-analysis in clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

The C terminus of p53 binds the N-terminal domain of MDM2.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

MDM2 SNP309 and risk of endometrial cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations and power

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-32-85

Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029393

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24423195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/24423195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24423195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-9966-32-85

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference